2,6-Dimethyl beta cyclodextrin; Dimethyl-β-Cyclodextrin;

Heptakis(2,6-di-O-methyl)-β-cyclodextrin is a cholesterol sequestering agent which modifies lipid rafts of the cell membrane. β-cyclodextrins are involved in cytotoxicity in various cells through complexation with cholesterol and membrane lipids.

Ionic forms of these molecules greatly reduce its cytoxicity compared to its methylated form. The cytotoxicity of β-cyclodextrins is affected by the position of the substitution of the methylated portion of the molecule.

The ability of a β-cyclodextrin to potentiate cytotoxic effects is dependent on the molecules ability to extract cholesterol from cell membranes. Alternate studies indicate that 2, 6-Di-O-Methyl-Beta-Cyclodextrin contains a stereoselective cavity only when the R substituent is linked to the chiral carbon which contains an aromatic ring.

Cosmetics and personal care products: 2,6-Di-O-Methyl-Beta-Cyclodextrin can be used in cosmetics and personal care products as a solubility enhancer and stabilizer. It can help improve the solubility of lipophilic ingredients and protect active components from environmental factors, enhancing the performance and stability of the products.

Food industry: 2,6-Di-O-Methyl-Beta-Cyclodextrin can be applied in the food industry as a food additive. It can act as a stabilizer, flavor fixative, and texture modifier, improving the texture, taste, and stability of food products.

Chemical and materials science: Due to its solubility and stability advantages, 2,6-Di-O-Methyl-Beta-Cyclodextrin can also be used in the chemical and materials science fields. It can serve as a solvent, catalyst support, or component of separation materials for various chemical reactions and separation processes.

Environmental science: 2,6-Di-O-Methyl-Beta-Cyclodextrin can find applications in environmental science, such as water treatment, pollutant removal, and soil remediation. It can form inclusion complexes with certain harmful substances, improving their stability and manageability.

Methyl-β-cyclodextrin (MβCD), also known as Methyl-beta-cyclodextrin, M-β-CyD, or Methyl-β-CD, is a cholesterol-depleting agent primarily used to disrupt lipid rafts. Methyl-β-cyclodextrin has demonstrated potential effective anti-tumor activity by inducing caspase-dependent apoptosis and inhibiting the growth and invasion of PEL (primary effusion lymphoma) cells without significant adverse effects.

Methyl-β-cyclodextrin is a cyclodextrin derivative that can form inclusion complexes with cholesterol molecules. By sequestering cholesterol, it disrupts the integrity of lipid rafts, which are specialized microdomains in the cell membrane involved in various cellular processes, including signal transduction.

Studies have shown that Methyl-β-cyclodextrin treatment induces caspase-dependent apoptosis in PEL cells. Caspases are a family of proteases involved in programmed cell death. The induction of apoptosis by Methyl-β-cyclodextrin leads to the inhibition of PEL cell growth and invasion.

Furthermore, Methyl-β-cyclodextrin has demonstrated potential as an effective anti-tumor agent with minimal adverse effects. Its ability to deplete cholesterol and disrupt lipid rafts provides a promising avenue for targeted cancer therapy.

Please note that while the described findings indicate potential anti-tumor activity of Methyl-β-cyclodextrin, further research and clinical studies are necessary to fully understand its efficacy, safety, and potential application in cancer treatment.

1. The quality is stable, has been audited by customers many times and received high praise, and provides technical support;
2. Binzhou Zhiyuan Biotechnology obtained ISO 9001, ISO14001, ISO45001 certification
3. Strong supply capacity
4. 2,000 square meters of high-standard GMP workshop